Oragenics, Inc. (NYSE:OGEN) has a beta value of 0.59 and has seen 15,935,119 shares traded in the last trading session. The company, currently valued at $38.2 Million, closed the last trade at $0.69 per share which meant it gained $0.13 on the day or 23.35% during that session. The OGEN stock price is -27.54% off its 52-week high price of $0.88 and 49.28% above the 52-week low of $0.35. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.46 Million shares traded. The 3-month trading volume is 2.85 Million shares.
The consensus among analysts is that Oragenics, Inc. (OGEN) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.08.
Oragenics, Inc. (NYSE:OGEN) trade information
Sporting 23.35% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the OGEN stock price touched $0.79 or saw a rise of 12.66%. Year-to-date, Oragenics, Inc. shares have moved 31.93%, while the 5-day performance has seen it change 29.46%. Over the past 30 days, the shares of Oragenics, Inc. (NYSE:OGEN) have changed 22.15%. Short interest in the company has seen 858.28 Million shares shorted with days to cover at 301.15.
Wall Street analysts have a consensus price target for the stock at $2.5, which means that the shares’ value could jump 262.32% from current levels. The projected low price target is $2.5 while the price target rests at a high of $2.5. In that case, then, we find that the current price level is +262.32% off the targeted high while a plunge would see the stock lose 262.32% from current levels.
Oragenics, Inc. (OGEN) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +18.7% over the past 5 years. Earnings growth for 2020 is a modest +57.6% while over the next 5 years, the company’s earnings are expected to increase by 0%.